Sign in

You're signed outSign in or to get full access.

Dale W. Boyles

Chief Financial Officer at WARRIOR MET COALWARRIOR MET COAL
Executive

About Dale W. Boyles

Dale W. Boyles, age 64, has served as Chief Financial Officer of Warrior Met Coal (HCC) since January 2017; he is a certified public accountant and previously held senior finance roles at Noranda Aluminum (CFO), Hanesbrands (Operating CFO, Interim CFO, CAO), KPMG (Audit Partner), and Collins & Aikman; he also provided consulting services to Warrior in late 2016 . In 2024, HCC generated $250.6M net income and $447.9M Adjusted EBITDA with sales volumes +6% YoY and production +8% YoY, and delivered annual incentive and PSU payouts of ~180% and ~190% of target respectively, underscoring strong pay-for-performance alignment during Boyles’ tenure as CFO .

Past Roles

OrganizationRoleYearsStrategic impact
Warrior Met Coal, Inc.Chief Financial OfficerJan 2017–PresentLeads finance through commodity cycles and the Blue Creek project; board liaison for ERM; also investor relations contact .
Warrior Met Coal, LLCConsultantNov–Dec 2016Transition advisory ahead of CFO appointment .
Noranda Aluminum Holding Corp.Chief Financial Officer2013–2016Oversaw Chapter 11 reorganization in 2016; managed liquidity under stress .
Hanesbrands, Inc.Operating CFO; Interim CFO; VP, Controller & CAO2006–2012Enterprise FP&A and controllership leadership at a large global issuer .
KPMG LLPAudit Partner, Consumer & Industrial Markets1997–2006Audited complex issuers; PCAOB/SOX expertise .
Collins & Aikman Corp.Corporate Division Controller1993–1996Segment finance leadership .

External Roles

OrganizationRoleYears
Forward Air CorporationDirectorCurrent

Fixed Compensation

Item202220232024
Base salary (earned)$448,024 $468,663 $491,506
Base salary (rate effective Mar 1, 2024)$495,957 (5.0% increase vs 2023)
Target annual bonus (% of base)100% 100% 100%
Actual annual bonus paid$896,048 $796,728 $882,499 (179.55% of target factor)

Perquisites and benefits (2024):

  • Company 401(k) match: $17,250
  • Insurance premiums: $25,545
  • Car allowance: $18,000; other minor perqs: $1,090
  • Dividends paid on vested/earned RSUs in 2024: $88,774

Policy guardrails:

  • Executive stock ownership guideline: 3× base salary; five-year compliance window; retain net shares until compliant .
  • Clawbacks: SOX-style recoupment and Dodd-Frank/NYSE-compliant policy with 3-year lookback upon restatement .
  • Hedging/pledging prohibited; no pledges by executives .

Performance Compensation

Annual cash incentive (2024 program mechanics and outcomes):

  • Metrics/weights: Adjusted EBITDA (20%), Capital Expenditures (20%), Metric Tons of Production (20%), Cash Cost/Ton (20%), Safety TRIR (20%) .
  • Company results drove a 179.55% payout factor applied to individual targets (Boyles’ target = 100% of base) .
MetricWeightThresholdTargetMaximumActualPayout contribution
Adjusted EBITDA ($)20%386,986,300 442,270,100 497,553,800 491,732,700 37.89%
Capital Expenditures ($)20%119,857,600 113,864,700 107,871,800 106,943,600 40.00%
Metric Tons of Production20%6,556,000 6,724,100 7,060,400 7,481,800 40.00%
Cash Cost/Ton20%Confidential Confidential Confidential ~11% better than target 40.00%
Safety TRIR20%4.39 1.54 1.46 1.53 21.66%
Total payout factor100%50% 100% 200% 179.55%

Long-term equity (time- and performance-based RSUs):

  • 2024 grants (Feb 8, 2024): Time-based RSUs vest ratably over 3 years; PBRSUs target = 13,243 with 3 one-year tranches (2024–2026) and metrics: longwall feet advanced (25%), continuous miner feet (25%), cash cost/ton (25%), and TSR vs peer group (25%); outcomes interpolate 0–200%/year; 2024 tranche paid at 190.45% .
  • 2023 and 2022 PBRSU grants also had 2024 tranches; all 2024 tranches paid concurrently on Feb 10, 2025 .
2024 equity activity for BoylesTarget sharesActual shares issued (Feb 10, 2025)
2024 PBRSU tranche (from 2024 grant)4,414/3 = 1-year PB target count shown separately below? See PBRSU table 8,406
2023 PBRSU tranche (2024 performance)6,783 (target) 12,918
2022 PBRSU tranche (2024 performance)7,835 (target) 14,922

PBRSU 2024 metric outcomes:

MetricWeightThresholdTargetMaxActualPayout (per metric)
Longwall feet advanced25%Confidential Confidential Confidential ~12% > target 50.00%
Continuous miner feet25%Confidential Confidential Confidential ~6% > target 40.45%
Cash cost/ton25%Confidential Confidential Confidential ~13% better than target 50.00%
TSR vs peer median25%20% below median Peer median (−29.72%) 20% above median HCC TSR (−9.69%) 50.00%
Total payout factor100%190.45%

2024 annual equity grant sizing (Boyles):

Grant dateTime-based RSUs (shares)PBRSUs target (shares)Method
Feb 8, 20244,414 13,243 Dollar targets converted at grant-date close; 25% time-based / 75% PBRSUs for his level .

Equity Ownership & Alignment

Ownership elementDetail
Beneficially owned common shares166,201 shares (<1% of outstanding) .
Unvested time-based RSUs at 12/31/20242/17/2022 grant: 2,612 shares; 2/8/2023 grant: 4,522 shares; 2/8/2024 grant: 4,414 shares (market values based on $54.24 close are disclosed in proxy) .
Unearned PBRSUs at 12/31/20242023 grant (eligible to earn in 2025): 6,783 target shares; 2024 grant (eligible in 2025–2026): 8,828 target shares (half each year) .
Upcoming vesting cadenceTime-based RSUs vest on each first, second, and third anniversary of grant; remaining 2,612 shares from 2/17/2022 vest on 2/17/2025; 2/8/2023 and 2/8/2024 grants vest ratably on those anniversaries (equal installments) .
Dividends on RSUs (2024)$88,774 paid on RSUs that vested or were earned during 2024 .
Ownership guidelines3× base salary; 5-year compliance window; must retain net shares until compliant .
Hedging/pledgingProhibited; no pledges by executives .

Employment Terms

  • Agreement: Indefinite term with minimum base salary, annual bonus opportunity, and participation in benefit plans .
  • Severance (no CoC): If terminated without cause or resigns for good reason, cash severance = 1× base salary (installments over 1 year) plus pro‑rated annual bonus if termination after Q3; vesting of equity that would vest within 30 days is preserved .
  • Change in control: Double trigger; if terminated without cause/for good reason within 12 months post‑CoC, lump sum = 1.5× base salary (2× for CEO) in lieu of standard severance; unvested equity generally settles at target upon CoC; time-based RSUs fully vest at CoC .
  • Non‑compete / non‑solicit: 12‑month non‑compete; 24‑month non‑solicit; perpetual confidentiality and non‑disparagement .
  • Golden parachute limits: No 280G tax gross‑ups in agreements; Board policy requires stockholder approval for future severance >2.99× salary + target bonus .
  • Clawbacks: Contractual recoupment plus Dodd‑Frank/NYSE clawback policy .

Potential payments snapshot (assumes Dec 31, 2024 event):

ScenarioCashEquity accelerationTotal
Termination w/o cause or for good reason (no CoC)$2,178,456 $2,178,456
Death/Disability/Retirement$800,000 $3,566,521 $4,366,521
Change in control (equity and Blue Creek awards per plan)$4,000,000 (Transformational Award target) $3,566,521 $7,566,521
CoC + qualifying termination$743,936 (1.5× base salary) $3,566,521 $4,310,457

Transformational Retention/Incentive (Blue Creek):

  • One-time cash award opportunity (threshold $1.0M to max $4.0M per NEO) based on on-time longwall start, capital spend, and production tonnes; awards cancel if Blue Creek production not commenced by April 25, 2028; payable pro‑rata at target on certain terminations; pays target upon CoC for NEOs (CEO requires CoC+termination) .

Say‑on‑Pay & Shareholder Feedback (Program Governance)

  • 2024 say‑on‑pay support was ~66%; Board/Compensation Committee engaged holders and committed to: no off‑cycle special awards during Blue Creek vesting period absent extraordinary circumstances, and double‑trigger CoC for all equity awards beginning in 2025 (CEO’s 2023 Transformational Award already had double trigger) .

Equity Vesting & Potential Selling Pressure

  • Scheduled time‑based vesting dates: 2,612 RSUs from 2/17/2022 vest on 2/17/2025; remaining 2023 and 2024 time‑based RSUs vest ratably on 2/8/2025, 2/8/2026, and 2/8/2027, subject to continued employment .
  • PBRSU issuance tied to annual performance tranches; for 2024, Boyles received 36,246 shares across 2022–2024 grants on Feb 10, 2025 (8,406 + 12,918 + 14,922) .
  • Insider trading policy prohibits hedging/pledging and requires trading windows; executives must retain net shares until ownership guidelines are met, tempering sell pressure .

Expertise & Qualifications

  • Education: B.S. in Accounting (UNC Charlotte); Certified Public Accountant .
  • Technical/industry: Public company CFO experience (manufacturing/commodities), restructuring leadership (Noranda Chapter 11), audit and reporting expertise (KPMG partner), and capital allocation oversight; serves on public company board (Forward Air) .

Investment Implications

  • Pay-for-performance alignment appears robust: 2024 annual bonus and PBRSUs paid 179.55% and 190.45% on operational, cost, and TSR metrics amid commodity volatility, indicating tight linkage of variable pay to controllable KPIs and relative returns .
  • Retention risk mitigants include multi‑year RSU vesting, stock ownership requirements (3× salary), and Transformational Award tied to Blue Creek milestones (award cancels if longwall is not on time), all of which incentivize continuity through major project ramps .
  • Potential cash outlay under CoC: Boyles could receive $4.0M Transformational Award at target upon a change in control, plus equity acceleration at target—important for M&A modeling of transaction costs and executive incentives .
  • Near‑term share supply from vesting looks manageable given retention/holding requirements and anti‑hedging/pledging policies; 36,246 PBRSU shares issued on Feb 10, 2025 plus scheduled time‑based vesting are partially offset by guideline-driven net share holding .
  • Governance trajectory is improving: commitments to double‑trigger equity for CoC and limiting one‑time awards responded to 2024 say‑on‑pay feedback (66% support), lowering future governance risk premia .